The Immunotoxin market accounted for USD 168.5 Million in 2024 and is expected to reach USD 388.9 Million by 2035, growing at a CAGR of around 7.9% between 2025 and 2035. The immunotoxin market includes firms that research, develop, and sell immunotoxins, which are bioactive molecules made up of a toxin and an antibody, or a combination of the two.
Okfun
Wc Decking & Waterproofing
Ongediertebestrijding Arnhem
Andrea Summer
River Valley Weight Loss
Da88
Lakeway Mobility
Go88
55hh
Vanilla Prepaid